Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized Placebo-controlled Study to Evaluate the Efficacy and Safety of TAK-475 50 mg, 100 mg, or Placebo When Co-administered With Atorvastatin (10 mg to 40 mg) in Subjects With Primary Hypercholesterolemia

NCT00143676 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00143676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00143676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized Placebo-controlled Study to Evaluate the Efficacy and Safety of TAK-475 50 mg, 100 mg, or Placebo When Co-administered With Atorvastatin (10 mg to 40 mg) in Subjects With Primary Hypercholesterolemia
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2005
Completion date
August 31, 2006
Enrollment
448 (actual)
Sites
78

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia